FangXiang Wu is a full professor in the College of Engineering, Department of Computer Science at the University of Saskatchewan, Canada. Dr. Wu received his B. Sc. degree and M. Sc. degree in Applied Mathematics from Dalian University of Technology, Dalian, China in 1990 and 1993, respectively. His first Ph.D. was in Control Theory and Its Applications from Northwestern Polytechnical University, Xi’an, China, in 1998, and the second Ph.D. was in Bioinformatics and Systems Biology from University of Saskatchewan, Saskatoon, Canada, in 2004. He worked as a postdoctoral fellow with Laval University Medical Research Center, Quebec City, Quebec.

Zhu-Hong You (M’14) received his B.E. degree in Electronic Information Science and Engineering from Hunan Normal University, Changsha, China. He obtained his Ph.D. degree in control science and engineering from University of Science & Technology of China (USTC), Hefei, China, in 2010. He was a postdoctoral research fellow respectively in Tongji University, Shanghai, China and in Hong Kong Polytechnic University. In July 2015, he entered into China University of Mining and Technology as Professor. In 2016, he joined the Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences as the Recipient of “Hundred Talents Program of CAS”.

Dr. Lei Chen is an associate professor of computer science at Shanghai Maritime University. He obtained his Ph.D. from East China Normal University, China, in 2010. His research interest includes bioinformatics, proteomics, computational biology, graph theory. Up to now, he has published 140 refereed papers. Google scholar showed that his papers have been cited more than 2300 times. Thirteen papers were selected as ESI Highly Cited Paper. Now, he serves as the section editor for this journal and Combinatorial Chemistry & High Throughput Screening, editorial board member for Current Bioinformatics, The Open Bioinformatics Journal, reviewer for Mathematical Reviews.

Dr. Manoj K. Kashyap obtained his Ph.D. degree (Specialty: Biotechnology) in 2011 in collaboration with Institute of Bioinformatics, Bangalore, India, and Johns Hopkins University, Baltimore, MD, USA. Since Sep 2017, Dr. Kashyap is an Assistant Professor at the School of Life and Allied Health Sciences, Glocal University, Saharanpur, India. Currently, he is involved in finding the molecular mechanism of RNA splicing using splicing modulators in gastro-intestinal cancers through genomics/proteomics approaches. He is also involved in targeting the receptor-ligand axis to overcome the protection by the tumor microenvironment. Dr. Kashyap, as an author/co-author, has published more than 35 articles in various journals.

Ravinder Abrol is an Assistant Professor of Biochemistry in the Department of Chemistry and Biochemistry at California State University Northridge, California. He received his PhD in Chemistry from California Institute of Technology. He has been applying chemical and biophysical principles to understand the role of protein function in signaling and to elucidate the molecular basis of specific diseases. He is developing computational methods to predict the structure and functional activity of GPCRs, to predict protein-protein interactions, and to rationally design drugs with minimal side-effects. The computational studies are tightly coupled to experiments to generate and test hypotheses about the role of specific proteins and mutations in the normal and disease state of cells.

Ruedi Aebersold is Professor of Systems Biology at the Institute of Molecular Systems Biology (IMSB) in ETH Zurich. His team uses quantitative mass spectrometry to differentiate cells in different states, and to systematically study how cells respond to external stimuli. This is expected to lead to new diagnostic markers for disease and to a more complete understanding of the biochemical processes that control and constitute cell physiology. Ruedi Aebersold is a pioneer in the fields of proteomics and systems biology and has developed a series of methods that have found wide application in analytical protein chemistry.

Dr. Amjad Ali working as an Assistant Professor at Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology (NUST),since in 2013. He has been actively pursuing a career in both academic and research. Amjad’sgroup produced interesting genomic and proteomic data and findings, thus far, he has contributed more than Ninety (90) Journals (Citations: 1532 and H-index 20) along with 11 book chapters. These International journals include Nature Neuroscience, ScientificReports,Frontiers in Microbiology, and Physiology, Integrative Biology, BMC Genomics and Bioinformatics and J. Bacteriology, etc. Amjad has secured several research grants (as PI andCo-PI), on a highly competitive ground. He also has supervised several PhD and Master Thesis.During the past years, Amjad Ali has been awarded the “Best Research Paper Award” for the year 2013/14 by Higher Education Commission (HEC) Pakistan (2016). Awarded “Best Researcher Award” for the year 2016/17 by ASAB, NUST. Later, awarded with “Research Productivity Award (RPA)” in Biological Sciences (2017) by Pakistan Council for Science and Technology (PCST), 2018.

Professor of Bioinformatics and Director of the Department of Human Protein Science at the University of Geneva, Amos Bairoch is head of the CALIPHO group of the SIB - Swiss Institute of Bioinformatics. Until June 2009, Amos headed the Swiss- Prot group which develops the UniProtKB/Swiss-Prot knowledgebase which he created in 1986 as well as the PROSITE and ENZYME databases. He was also co-responsible for the development of ExPASy, the world’s first website dedicated to protein molecular biology. Amos Bairoch’s main work lies in the field of protein sequence analysis and the development of databases and software tools for this purpose. Currently his main activities are focused on the development of neXtProt, a web knowledge platform on human proteins and of the Cellosaurus, a cell line knowledgebase. Amos Bairoch has been awarded several distinctions, among which the European Latsis Prize, the Otto Naegeli Prize and the HUPO Distinguished Achievement Award. He is an ISCB Fellow.

Dr. Banerrji is a Biochemist trained at The Scripps Research Institute, USA and the Max-Planck Institute for Biophysical Chemistry, Germany. He is currently, an Associate Professor of Biochemistry; and with clinical research focusing on lipid and lipoprotein metabolism, metabolomics, toxinomics (especially concerning arthropod and reptilian venom), coagulation biochemistry and anticoagulants; is involved in medical education, curriculum and course-design and delineation of student assessment policies. He is the lead author on several key publications concerning lipid metabolism and anticoagulants and has two international patents.

Dr. Marilena Budroni obtained her Degree in Agricultural Sciences and PhD in Microbial Biotechnologies at the University of Sassari; Postgraduate in Viticulture and Oenology. She is an Associate Professor in Microbiology, at the University of Sassari. Dr. Budroni Research activities focused on the genetic and physiology of microorganisms of biotechnological interest, more recently focused on brewer yeast strains. Author and co-author of 120 scientific papers including 50 peer reviewed articles on international journals indexed by Scopus and WoS, H index 16. PI of national projects.

Fabrizio Ceciliani, DVM, PhD, is an Associated Professor of Veterinary Pathology at the University of Milano. He graduated in Veterinary Medicine at the University of Milano. In 1994 gained a PhD in Biochemistry and in 1995 gained a post doc position in Molecular Biology at the University of Milano. Current interests include the immune response in white blood cells and the involvement of adipose tissue in innate immune response. He teaches Molecular Pathology at the School of Veterinary Biotechnology of the University of Milano.

Dr. A. Chambery is the Chair in Biochemistry at the Pharmacy Course, Second University of Naples (SUN) and Head of the “Mass spectrometry and Proteomics” lab at the DiSTABiF Department (SUN). Dr. Chambery has a long-standing experience in the field of biochemistry, proteomics and mass spectrometry. Recently, Dr. Chambery devoted much research time to investigate the molecular profile of cellular secretomes with the aim of deciphering the molecular crosstalk between cells and tissues under physiological and pathological conditions. Dr. Chambery has authored more than 100 manuscripts, in ISI peer-reviewed journals.

Dr. Lei Chen is an Associate of computer science at Shanghai Maritime University. He obtained his Ph.D. from East China Normal University, China, in 2010. His research interest includes bioinformatics, computational biology, graph theory, graph algorithm, algorithm design. Up to now, he has published more than 130 refereed papers. Google scholar showed that his papers have been cited more than 2000 times. Thirteen papers were selected as ESI Highly Cited Paper. Now, he serves as the section editor for Combinatorial Chemistry & High Throughput Screening and Current Bioinformatics, editorial board member for The Open Bioinformatics Journal, reviewer for Mathematical Reviews.

Xing Chen Professor of School of Information and Control Engineering, China University of Mining and Technology and founding director of Institute of Bioinformatics, China University of Mining and Technology. He serves as associate editor, editorial board member or lead guest editor for academic journals such as BMC Systems Biology, Scientific Reports, Current Protein & Peptide Science, Frontiers in Microbiology, Current Medicinal Chemistry, International Journal of Molecular Sciences, Current Topics in Medicinal Chemistry. In recent years, he published 83 SCI papers in the journals such as Bioinformatics, PLOS Computational Biology, Nucleic Acids Research, Briefings in Bioinformatics, Cell Death & Disease.

Celso Cunha has a PhD in Biology from Lisbon University. He leads a research group whose main interests are related to the molecular and celular biology of Hepatitis B and D viruses. Celso Cunha is author of more than fourty publications in peer-reviewed journals. He has and extensive experience of revieweing manuscripts for several journals and project evaluation for different funding agencies. Celso Cunha is currently Associate Professor of Microbiology in the Institute of Hygiene and Tropical Medicine, NOVA University, Lisbon where also coordinates a Master program in biomedical sciences.

Dr. D’Auria is the Director of the Institute of Food Science, CNR, Avellino, and an Associated Professor at INRS, Laval, Canada. He also heads the Laboratory of Protein Biophysics and Biosensor Development at ISA-CNR, Avellino, Italy. The main interests of Dr. D’Auria Lab are focused on the design and realization of advanced bio/sensors for safety and security. Dr. D’Auria has authotred more than 200 publications on international journals and several national and international patetnts.

Dr. Norelle Daly obtained a Doctorate in Biochemistry from The University of Queensland, Brisbane. Her research involves the use of NMR spectroscopy to study peptides with therapeutic potential, and she has been centrally involved in determining the structures of more than 50 cystine-rich peptides including peptides isolated from plants, cone-snails, bacteria, spiders and frogs. She has authored more than 150 manuscripts and is an inventor on three patents. Currently she is a Professor at James Cook University, Cairns where her research focuses on peptides involved in anti-inflammatory diseases and wound healing.

I graduated Ege University Medical Faculty, Turkey, in 1986, I took Physiology Specialty in Ataturk University of Turkey. I worked as professor in Ataturk, Fatih and Turgut Ozal Universities in Turkey. I became emeritus in Turkey. Now, I am working in Nile University of Nigeria and Head of Physiology Department.

Dr. Didier Devaurs currently works in the fields of structural bioinformatics and biomedical computing at the University of Grenoble Alpes, France. His research focuses on the development of new computational methods for the structural modeling and analysis of proteins and molecular complexes. Dr. Devaurs holds a BSc in computer science and a BSc in mathematics from the University of Clermont-Ferrand, France. He earned an MSc in computer science from the University of Lyon, France, with major in knowledge and reasoning. He received his PhD in artificial intelligence from the INPT, University of Toulouse, France

Dr. Sebastien Dutertre was awarded his PhD from the University of Queensland (Australia) in 2006. He then obtained an EMBO postdoctoral fellowship to work at the Max-Planck Institute for Brain Research (Germany) in the laboratory of Professor Heinrich Betz on the structure-function of ion channels (2006-2007). Next, he joined Atheris laboratories (Switzerland) to work on a European funded project dedicated to the discovery and development of venom peptides as therapeutics. In 2010, he was awarded a UQ postdoctoral fellowship to join Prof. Richard Lewis’ groups at the Institute for Molecular Bioscience, and since 2014, he holds a permanent position at the CNRS, University of Montpellier (France) where he developed an integrated approach to accelerate the discovery of novel peptides from animal venoms.

Afaf El-Ansary, female, biochemist, graduated from biochemistry department, Ain Shams University, Egypt in 1974. She worked in the National Reserch Centre, Egypt from 1976-2000, from 2001-2015 she work as teaching staff member in biochemistry department, King Saud University, KSA. Since 2016, she is working as senior scientist in the central laboratory, KSU. She was recognized by the Marquis Who's Who in science and engineering, Eight's edition, 2005-2006. She is member in number of national and international societies and she is recorded as reviewer and editorial board member in many international journals. In recent years she focused on the screening of biochemical markers related to autism with special attention to the role of gut-brain axis and she got more than 140 published papers in high impact factor Journals related to this research interest. She is member in Predictive, Preventive and Personalized Medicine Society (Moscow).

Dr. Ge is a Professor of Institute of Hydrobiology (IHB), Chinese Academy of Sciences (CAS). He is the awardees of Hundred Talents Program of CAS, Leader of Functional Proteomics Group of IHB. His group is using state-of-the-art mass spectrometric methods for identification of proteins and for characterizing post-translational modifications in signal transduction pathways and in the analysis human and several different organisms. They are using different techniques to quantitate levels of protein as well as post-translational modifications. They are also developing computational methods that allow us to extract annotated information from existing databases including genomic databases while performing searches using MS-derived data.

Dr. Stefania Gonfloni received a Degree in Biology (LAUREA in Scienze Biologiche, University of Rome "Tor Vergata" Summa cum laude) in 1991. She did Masters in Biophysics (International School for Advanced Studies/ISAS Trieste Italy) in 1993. Later, she did PhD in Biophysics (International School for Advanced Studies/ISAS Trieste, Italy) in 1995. Since 2001, Dr. Gonfloni is an Assistant Professor, Dept. Biology, University of Rome.

Kyungsook Han is a professor at the Department of Computer Science and Engineering, Inha University, Incheon, Korea. She received a BS cum laude from Seoul National University in 1983, an MS cum laude in Computer Science from Korea Advanced Institute of Science and Technology (KAIST) in 1985, another MS in Computer Science from the University of Minnesota at Minneapolis, USA in 1989, and a PhD in Computer Science from Rutgers University, USA in 1994. Her research areas include bioinformatics, visualization, and learning.

Dr. Rasmus Hartmann-Petersen is an associate professor at the Department of Biology, University of Copenhagen, Denmark. He has nearly 20 years of experience in research on protein misfolding, degradation and the ubiquitin-proteasome system. In his research Dr. Hartmann-Petersen utilizes a combination of genetics, cell biology and proteomics techniques on yeast and mammalian cells.

Dr. Herman obtained his doctorate (Ph.D.) in biophysics from the Charles University, Czech Republic. Currently Dr. Herman is a full professor of molecular and biological structures at the Charles University, Faculty of Mathematics and Physics in Prague. He has published more than 90 scientific publications and is a named inventor of 6 issued U.S. and Czech patents.

Hubert Hondermarck is Professor of medical biochemistry at the University of Newcastle (Australia). Hubert has over 25 years of experience with cancer proteomics, starting with 2D electrophoresis and up to now with high-resolution mass spectrometry analyses. He received a PhD in neurobiochemistry from the University of Lille (France) and was a postdoctoral fellow at the University of California Irvine where he worked on deciphering neuronal cell signaling by using proteomics. He was first to discover the role of neurotrophic growth factors in breast cancer and was head of a cancer research unit at the French National Institute of Health. Hubert was also the Chair of the French proteomics society and a member of the HUPO board of directors. Hubert current research involves proteomics and focuses on studying the crosstalk between the nervous system and cancer, with the objective of translating this basic knowledge into innovative new strategies for cancer management.

Dr. Christian W. Huck currently holds a position of a full professor for analytical chemistry at Leopold-Franzens University of Innsbruck, Austria. Currently, Prof. Huck is also guest professor at Kwansei Gakuin University (Sanda, Hyogo, Japan). He has published more than 200 scientific publications describing new analytical attempts in vibrational spectroscopy (different modes of infrared and Raman) and separation science including mass spectrometry (LC, SPE, CE, CEC, -MS, MALDI) and is a named inventor of 14 issued international patents. Prof. Huck has received several international awards (e.g., Buechi, Euregio, Swarovski etc).

Esther Imperlini is a post-doctoral research associate at IRCCS SDN of Naples, Italy and Adjunct Professor at Department of Movement Sciences and Wellness, University of Naples ‘‘Parthenope’’, Italy. She obtained her PhD in Chemical Sciences from the University of Naples ‘‘Federico II’’; her Residency in Clinical Biochemistry from the University of Naples ‘‘Federico II’’; and her post-doctoral training from CEINGE-Biotecnologie Avanzate s.c.a r.l. of Naples, Italy. She currently focuses on the physiopathological processes in biomedical fields through the most advanced methods in proteomics.

Setsuko Komatsu is a Chief of Field Omics Research Unit at National Institute of Crop Science and a Professor at University of Tsukuba, Japan. She employed at Meiji Pharmaceutical University and then also Medicine at Keio University, school of Medicine. Since 1990, she started working on plant proteomics using protein sequencer and mass spectrometry by a present official position. Her main research interests are within the field of crop proteomics, biochemistry and molecular biology with a special focus on signal transduction in cell. She has authored more than 300 manuscripts on plant omics research.

Dr. Sotirios Koutsopoulos is a researcher in the Center for Biomedical Engineering at Massachusetts Institute of Technology. Dr. Koutsopoulos’ research is focusing on the design of novel peptides sequences with many applications including membrane protein purification and stabilization, tissue engineering, organ regeneration, drug delivery, neurodegenerative diseases, and immunoengineering. He has consulted with many biotech companies, holds three patents on the applications of self-assembling peptides, serves as member of the Editorial Boards in two journals and has published over 60 research articles and book chapters.

Mahesh Kulkarni is a Scientist at Biochemical Science Division at CSIR-National Chemical Laboratory. His research group is involved in characterization of Advanced glycation end products in diabetes using proteomic approaches and investigate their role in pathogenesis of diabetes and its complications. The long-term goal is to identify diagnostic markers for various diabetic complications, identify drug targets and develop intervention strategies.

Dr. Garlapati received his Ph.D. in Microbial (Enzyme) Technology from IIT Kharagpur, India with M.Tech (Biotech) and B.Pharm as his Master's and Bachelor's Degrees, respectively. He has around ten year's experience as a teacher/ researcher, including 2-years post-doctoral stay at UAB, Spain. He is a recipient of A4U Postdoctoral Fellowship (Spain), Institute Fellowship (IIT KGP) and GATE Fellowship. He is serving as an International Advisory Panel Member, Elsevier; EBM in "Frontiers in Bioengineering and Biotechnology". He has been a part of 2 Indian patents, published 37-Scopus/SCI- papers & 20 Book chapters, Edited 1 Book and guided several Ph.D./ M.Tech / B.Tech students.

Dr. Kamel Laghmani obtained his Ph.D. degree (in 1997) in Endocrinology and Cellular Interactions from University Paris 6, Paris, France. Dr. Laghmani is currently Group Leader (CR) and Principal Investigator at the National Centre for Scientific Research (CNRS), Paris, France. His skills and expertise mainly lie in the subject areas/fields of PCR, Molecular Biology, Protein, Genetics, Cell Biology, Hypertension, Biochemistry, Physiology, Protein-Protein Interaction, etc. Dr. Laghmani has published over 25 manuscripts and his documents have citations greater than 840.

Claire Lemaire is biochemist specialized in membrane proteins at the Institute for Integrative Biology of the Cell (I2BC) in Gif-sur-Yvette (France). She began her career in the photosynthesis field on the assembly and regulation of photosynthetic complexes (I.B.P.C., Paris). She then joined the C.N.R.S. (French National Center for Scientific Research) where she acquired a solid expertise in the respiratory complexes. These last years, she has developed a research project with her group focusing on the regulation of mitochondrial proteins by phosphorylation combining molecular biology, biochemistry and mass spectrometry.

Dr. Lovas obtained his formal training in chemistry in Hungary at the József Attila University and the Biological Research Center of the Hungarian Academy of Sciences, Szeged. In 1990, he joined Creighton University where he is a Professor of Biomedical Sciences. His research deals with conformation-biological activity relationships of polypeptides and description of solution structure of polypeptides by molecular dynamics simulations, ab initio quantum chemical calculations and chiroptical spectroscopy. He has published over 140 scientific publications.

Currently a lecturer in Physiology at NUI Galway and previously worked as a lecturer at the Institute of Ageing and Chronic Disease, University of Liverpool. My primary research focuses on disrupted redox signalling and its relationship to mitochondrial dysfunction in a variety of physiological models in particular skeletal muscle and neuromuscular junctions during ageing. One of the key features of age-related diseases such as neurodegeneration and sarcopenia is the loss of flexibility required for efficient redox signalling that regulates cellular pathways including mitochondrial dynamics, autophagy and proteasomal degradation, ER stress and activation of key transcription factors.

Prof. Angela Messina is Associate Professor of Molecular Biology at the University of Catania (Italy). Her research activities focused on the study of the structure/function relationships of transmembrane mitochondrial transport proteins with special emphasis on channel-forming protein porin (VDAC or Voltage Dependent Anion selective Channel). Prof. Messina has co-authored more than 80 scientific publications on international journals indexed by Scopus and WoS, H index 23. PI of national projects.

Associate Professor Molloy is Director of the Australian Proteome Analysis Facility, Macquarie University, Sydney, Australia and has over 20 years expertise in the application of proteomics and mass spectrometry for biomedical research. Molloy was a research fellow at the University of Michigan Medical School and a Senior Principal Scientist at Pfizer Inc., using proteomics for drug discovery. He has over 100 publications where his research is focused on new method development and applications of proteomics in translational cancer research.

I received my Ph.D. in Molecular Genetics in 2014, and my postdoctoral degree in Pharmaceutical Biotechnology from Pharmaceutical Sciences Research, Shiraz University of Medical Sciences in 2017. Presently, I have published more than 40 papers in the fields of vaccine design, and protein engineering. My fields of interest are industrial biotechnology, bioinformatics, systems biology, and immunoinformatics.

Dr Gianna Palmieri is Researcher of the Institute of Biosciences and Bioresources at National Council of Research (IBBR-CNR). She got her degree in Chemistry (1989) and a Specialization in Advanced Biotechnology (1994) at University of Naples. She attended (1990-1991) the Department of Chemistry at MIT, Boston (USA). She is a senior group leader and her research focus on structure/function relationship of proteins and enzymes and their biotechnological applications. She is scientific responsible and/or coordinator of several European and Regional projects. She is reviewer of international journals and she has authored 50 publications on international peer-reviewed journals receiving over 2500 citations.

Dr. Konstantinos Papadimitriou received his B.Sc./M.Sc. in Food Science and Technology from the Agricultural University of Athens (AUA, 1998), Greece. He pursued an additional M.Sc. degree in Genetic Manipulation and Molecular Biology from the University of Sussex (2000), UK. Later on, he received his Ph.D. degree in Food Microbiology with a specialization in Dairy Microbiology from AUA (2006). Dr. Papadimitriou has worked in different research projects gaining extensive postdoctoral experience of more than ten years in the technological properties, the Physiology, the Genetics and the Genomics of lactic acid bacteria. He is currently involved in the Metagenomics of fermented foods.

Dr. David Sánchez Peñaranda obtained his Ph.D. degree in 2008, with focus on the evaluation and cryoconservation of gametes, from Technical University of Valencia, Valencia, Spain. Dr. Peñaranda is currently working in the department of Higher Technical School of Agricultural Engineers at Technical University of Valencia. His skills and expertise mainly lie in the subject areas of Animal Production, Animal Physiology, Animal Genetics, Semen Analysis, etc. Dr. Peñaranda, as an author/co-author, has published more than 55 articles in various journals, having over 690 total citations.

Dr. Ning Qiu research areas include Avian Egg Protein Nutrition and functions. He obtained his Bachelor’s Degree in Bioengineering from Jiangnan University in 2000 and a PhD in Microbiology from Huazhong Agricultural University in 2010. Currently, he is an Associate Professor at Huazhong Agricultural University. He has a number of honors and scientific publications to his credit.

Dr. Ruvo graduated in Chemistry at the University of Naples in 1991. He spent the first 10 years of his career as industrial researcher (Tecnogen, Italy), working as head of the protein and peptide laboratory and contributing at the development of several bioactive peptides. In 2002, he joined the Institute of Biostructures and Bioimaging of the National Research Council (IBB-CNR) in Naples, working as senior scientist and leading several projects focused on the development of new bioactive peptides and monoclonal antibodies against targets with a role in cancers development. Among the others, he has developed peptides modulating the activity of PlGF, Cripto, and Gadd45β and mAbs against Nodal, the E2 protein of HCV and Cripto. He is also the scientific founder of Kesios Therapeutics Ltd (London). He is author of about 100 papers and inventor of >10 patents.

Dr. Kazuyasu Sakaguchi received his Ph.D. in Biochemistry at Kyushu University, Japan in 1989. In 1989, he joined a group of Dr. Ettore Appella at National Institutes of Health, National Cancer Institute, USA. From 1989 to 1999, he was a postdoctoral fellow, associate fellow, and staff scientist at the NIH. He moved to Kyushu University as an Associate Professor in 1999. In 2003, he joined to the Department of Chemistry, Hokkaido University as a full Professor. His recent research has focused on structure and function of tumor suppressor protein p53, especially the tetramer formation of p53, and function and regulation of oncogenic protein phosphatase PPM1D. His research interest also includes development of functionalized nanowire based on self-assembly of modified amyloid peptides. Dr. Sakaguchi has published more than 130 articles (total citations are over 13,000 and h-index is 52).

Salvatore Sechi received his Doctoral degree in biology/biochemistry from the University of Padua in Italy in 1987. He joined the National Institutes of Health as a Fogarty fellow in 1990. While a Fogarty fellow he was trained in protein chemistry; he contributed to the cloning of several novel genes and patented several unique methods for protein sequence analysis. In 1995, he joined, as research associate, the Laboratory of Mass Spectrometry and Gaseous Ion Chemistry at The Rockefeller University, where he developed several novel methods for protein characterization and quantification by mass spectrometry. In 1998/99 he worked as a principal investigator at Dupont and was appointed as a visiting professor at the University of Padua. In 2000 Dr. Sechi was appointed head of the mass spectrometry unit at the National Institute on Aging, and in 2001 he accepted his current position as Program Director in Proteomics and Systems Biology at the National Institutes of Diabetes and Digestive and Kidney Diseases. In his current role, Dr. Sechi has been managing several projects that are at the forefront in the application of proteomics to human diseases.

Mustafa Kemal Sezgintürk is a Professor in the Bioengineering Department at the Çanakkale Onsekiz Mart University where he has been a faculty member since 2016. He completed his Ph. D. at Biochemistry Department of Ege Univesity in 2007, Professor Sezgintürk has more than 80 publications and his works are referred over 1500 times in refereed journals, in the field of biosensors. In 2016, He has won the Awards for Outstanding Young Scientist (TÜBA-GEBİP), which is one of the prestigious scientific award.

Dr. Guang Song is currently an associate professor of computer science, computational biology and bioinformatics at Iowa State University. He obtained his Masters degree in Physics and PhD degree in Computer Science from Texas A&M University. He has published over 50 scientific publications. His work on mapping ligand migration pathways in dynamic proteins received the NSF CAREER award.

Nic Taylor completed his undergraduate studies and MSc at Massey University, New Zealand and in 2000 moved to The university of Western Australia to undertake his PhD. After his PhD he was awarded and European Molecular Biology Organization Long Term Fellowship to study at the Department of Plant Sciences at the University of Oxford, UK. He was recruited back to UWA in 2006 to the newly established ARC Centre of Excellence in Plant Energy Biology. Here he has applied and developed a wide range of quantitative proteomics approaches and used these in a wide range of research projects. His lab seeks gain a comprehensive understanding of how metabolites, proteins and lipids within plant cells respond to extremes of temperature and salt.

Hernán Terenzi received his Ph.D. in Biochemistry from Universidade de São Paulo, São Paulo, Brazil (1993). After postdoctoral training at the Institut Pasteur, Paris, France, he returned to Brazil to the Universidade Federal de Santa Catarina as an adjunct professor (1998) and is currently Full Professor of Biochemistry. The Terenzi laboratory studies structure/function relationships in phosphatases and also bioinorganic models of metalloenzymes. Current projects address the development of tyrosine phosphatase inhibitors and mechanisms of activity modulation, as well as the search for novel metal artificial hydrolases. He is a research fellow from the National Council for Scientific and Technological Development (CNPq).

Dr Thevis (*1973) graduated in organic chemistry and sports sciences in 1998. He earned his PhD in Biochemistry in 2001 and did post-doctoral research at the Department of Chemistry and Biochemistry of the University of California Los Angeles (UCLA) in 2002. After being a senior researcher from 2003 to 2005 he was appointed as Professor for Preventive Doping Research at the German Sport University Cologne in 2006. Mario Thevis further qualified as Forensic Chemist, acts as director of the European Monitoring Center for Emerging Doping Agents (EuMoCEDA), and is Editor-in-Chief of DRUG TESTING & ANALYSIS. Since 2014, Professor Thevis is also vice president for research at the German Sport University Cologne.

Dr. J. Yang received his PhD degree from Georgia State University in Molecular Genetics and Biochemistry. After his postdoc training at the Centers for Disease Control and Prevention (CDC), he returned to China and became a faculty member at Zhejiang University School of Medicine. He moved to Hangzhou Normal University in 2010 and also held a joint appointment at the National Key Laboratory for the Diagnosis and Treatment of Infectious Disease, Zhejiang University. His research interest focuses on the understanding of the DNA damage response using systems biology approaches. He has co-authored over 150 peer-reviewed publications.

Dr. Young Yang obtained his MS degree in 1990 from the Advanced Institute of Science and Technology, Korea. Later, he received a Ph.D. from the same Institute in 1997. His skills and expertise are in Gene Regulation, Transcription, Transcription Factors and Alternative Splicing. He is presently serving and working as a professor at the Department of Biological Sciences, Sookmyung Women's University in Korea.

Fei Ye received a BS degree in Pharmacy from Zhejiang University in 2008 and earned a PhD in Drug Design from Shanghai Institute of Materia Medica, Chinese Academy of Sciences in 2013. In the same year, she was recruited to Zhejiang Sci-Tech University as an Associate Professor. She is currently focusing on the discovery of novel lead compounds against various targets of diseases, such as bacterial infection and cancers, by combining theoretical and experimental techniques.

Professor Bi was born in Lanzhou city, China. He received his B.S. in Biochemistry from Lanzhou University and his Ph.D. in Pathogen Biology from Chinese Academy of Preventative Medicine. After postdoctoral training in Biochemistry and Molecular Biology at the National Cancer Institute, National Institutes of Health, USA, he returned to Chinese Academy of Sciences to begin his independent career as a principal investigator in 2008. He currently is a tenured full professor of Biochemistry and Molecular Biology, Cell Biology, and Genetics. He also serves as the associate dean of College of Basic Medical Sciences, Chair of Biological Sciences at Dalian Medical University.

Luisa Carlota Lopez-Cara was born in Granada. 1999 Degree in Pharmacy, 2005 PhD in Pharmaceutical Sciences 2005-2009 Post-Doctoral Fellowship Department of Pharmaceutical Sciences of the University of Ferrara and Department of chemistry of Emory University. 2009- 2012. Researcher in Department of Medicinal and Organic Chemistry of University of Granada. 2012-today Associate Professor It was engaged in the study of bioactive molecules with antiproliferative and antiangiogenic effects. Actually her research interests concern the design, synthesis and SARs study of new molecules endowed with antiproliferative activity both in vitro and in vivo and in particular of the mechanism that lead to cell death. She is author of about 74 scientific papers in qualified peer review journals. She is holder of many Spanish and European patents concerning the antitumoral molecules.

Giovanni Chiappetta is Research Engineer at CNRS France since 2010. He has a chemist formation and is specialist of mass spectrometry and protein chemistry. He gets its PhD in chemistry in 2009 with a joint thesis between University of Naples Federico II and University of Paris Pierre et Marie Curie. He gets the French “Hablitation à la direction des recherches” (HDR) in chemistry in 2018. Its field of interest is the study of the cysteine oxidative PTMs. More precisely he focuses its activity on the analytical aspects of the detection and quantification of PTMs combining organic chemistry, protein chemistry and mass spectrometry.

Dr. Somchai Chutipongtanate obtained a Doctorate in Immunology from Mahidol University and fully trained in Pediatrics specialty at Ramathibodi Hospital, Thailand. His current research involves the use of proteomic technologies including 2DE-MS and DIA/SWATH-MS for better understanding of complex pathophysiology of kidney diseases and discovery of candidate biomarkers in urine and exosome biomarkers with consistent results. Dr. Chutipongtanate also works in collaborations with basic scientists and clinicians in the area of pediatric translational medicine involving cellular immunotherapy in oncology, discovery new therapeutic targets in pediatric diseases and deciphering protective effects of human breast milk by peptide-based technology.

Dr. Gülsüm Özlem Elpek has obtained MD and Ph.D. (Pathology) from the Akdeniz University Medical School, Antalaya, Turkey. She has been teaching the residents pathological aspects of gastrointestinal, liver and pancreatic diseases since 2000. Most of her teaching sessions involve macroscopic and Histopathological evaluation of surgical resections and biopsy materials. Dr. Elpek has published more than 100 peer-reviewed articles in the field of Surgical Pathology. She is a member of Turkish Society of Gastroenterology, Turkish Society of Pathology, Turkish Association for the study of the liver, and European Society of Pathology.

Currently I work as a senior researcher at Chalmers University in Sweden. My research involves analytical methods like mass spectrometry and chromatography and is focused on compounds generated by the photosynthetic process in plants. From 2014 - 2018 I trained as a postdoctoral scholar at the VU University in Amsterdam. From 2011 to 2014 I worked as a postdoctoral fellow at the University of California in Los Angeles, US. I obtained my PhD degree in 2011 from Linkoping University in biochemistry with a focus on proteomics and mass spectrometry methods.

Dr. Giri did his PhD from Sapenza University of Rome, Italy and later postdoc from McMaster University. Dr Giri works on Intrinsically Disordered Proteins and the folding perspectives. He also works on Zika virus, Chikungunya virus and other emerging infectious diseases.

Dr. Fei Guo is an Associate Professor in the School of Computer Science and Technology, Tianjin University. She received the B.S. degree and the Ph.D. degree from Shandong University, in 2007 and 2012, respectively. She was a Postdoctoral Fellow at City University of Hong Kong between 2012 and 2013. Her research is in the areas of bioinformatics, computational biology, machine learning, and proteomics. She has published more than 40 SCI papers. Several related works have been published by Bioinformatics, Journal of Chemical Information and Modeling, RECOMB2013, ISMB2014, etc.

I am presently working as Associate Professor at King Abdulaziz University, Jeddah, Saudi Arabia. After completed my Ph.D. (Botany; specialization in Plant Ecophysiology and Molecular Biology) from Jamia Hamdard, New Delhi, India in 2011. I have authored and edited more than 33 books with International publishers, including Springer Nature, Academic Press (Elsevier), CRC Press etc. I have also to my credit more than 71 research publications in peer reviewed international journals and 49 book chapters in edited volumes with international publishers. At the present, I am serving as the Editorial board member and reviewer of several high impact international Scientific Journals.

Mohd Nazri Ismail is a Senior Lecturer in the Analytical Biochemistry Research Centre (ABrC) at Universiti Sains Malaysia (USM). Nazri received his Bachelor of Science (Biochemistry, Hons.) degree from Universiti Kebangsaan Malaysia and Doctor of Philosophy (PhD) in Molecular Biosciences from Imperial College London. During his PhD training under the supervision of Anne Dell and Stuart Haslam, he studied the O-glycan structures in health and disease conditions of a mouse model. His current research focuses on mass spectrometric characterisation of proteins, lipids and small molecules in medicinal plants and animals. To date he has published over 20 journal articles and two research books.

Dr. Nayak is an Associate Professor in Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University (LPU), India. He is also a member of review panel for research project proposals of SERB (DST, GoI) and panel member of Department Doctoral Board for Chemistry (LPU) and reviewer of various scientific journals. He has more than 13 years of experience in research and teaching (Medicinal Chemistry) aimed at identification of novel molecular probes for protein interaction study. He has published and presented more than 60 papers and has supervised more than 20 scientific projects for UG and PG students.

Dr. Son Tung Ngo is head of the Laboratory of Theoretical and Computational Biophysics at Ton Duc Thang University, Ho Chi Minh City, Vietnam. He has been applying computational studies to understand the conformation of misfolding proteins, structural change of metalloproteins, and the nature of protein-ligand interactions. He is investigating the misfolding structure of Aβ peptides in various environments in order to enhance AD therapy by using extensive and intensive MD simulations. The structure change of metalloproteins is currently evaluating by using both MD and QM calculations. He is also developing computational approaches to estimate the binding free energy between protein-ligand. The potential inhibitor for Aβ peptide, AChE, BACE1, etc. is screening via the binding affinity estimation.

Youxiong Que is a Professor in the College of Crop Science at the Fujian Agriculture and Forestry University (FAFU), China. He received his Ph.D. degree in Biochemistry and Molecular Biology from the College of Life Science in 2008 in FAFU. He then joined the College of Crop Science as a Plant Biotechnologist. He was employed as an assistant professor in 2008, promoted to be an associate professor in 2010 and a professor in 2015. From 2011, he was appointed as the vice director of Key Laboratory of Sugarcane Biology and Genetic Breeding, Ministry of Agriculture, China. His research interests are in the fields of crop especially sugarcane biotechnology, mainly focusing on the molecular interactions between crops and pathogens.

Dr. Divakar Sharma, Ph.D., is a biotechnologist recognized in the field of Microbial Proteome research, particularly for Tuberculosis and other diseases (especially in Drug resistance and Drug-induced studies). Dr. Sharma has studied at many universities and holds multiple degrees, including an M.Sc. degree in Biotechnology from the C.S.J.M. University, India, and a Ph.D. degree in Biotechnology from the Jiwaji University, India. He is distinguished as one of the best researchers in the field of microbial proteomics and Bioinformatics. Dr. Sharma has published over 25 research articles in journals of international repute, and serves as Editorial board member as well as Reviewer for several journals.

Dr. Sun is an associate professor of Core Instrument Facility, Institute of Basic Medical Sciences, Peking Union Medical College. He is responsible for mass spectrometry section in Core Instrument Facility. His group focuses on the biomarker discovery from body fluid proteomics, including urine, serum, saliva etc.They used various proteomic techniques to large-scale proteomic analysis, including labeled methods, iTRAQ and TMT, and label-free methods, DIA and SWATH.They also develop new methods for the applications of proteomic techniques to clinical diseases.

Dr. Tang received his M.D. from Chongqing Medical University, and Ph.D. from Chongqing University. Currently, he is the director of the Digestive Cancer Center of The First Affiliated Hospital, Wenzhou Medical University. He investigated and explored that Dicer, a key enzyme in the RNAi pathway, is essential for genome stability. The goal of Tang laboratory is to understand the role of Dicer in DNA damage, inflammation and cancer.

Dr. Liangliang Xu obtained his PhD Degree from the department of orthopaedics and traumatology, the Chinese University of Hong Kong in 2012. In the last ten years, his focus was on the basic and applied study of mesenchymal stem cells, and emphasized studying the basic factors and related signaling pathways that regulate proliferation, apoptosis and differentiation of mesenchymal stem cells. In the year 2016, he joined in Guangzhou University of Chinese Medicine as a Professor. Overall, Dr. Xu has published 38 SCI papers, including 15 papers as the first author and corresponding author.

Dr. Tao Zhou obtained his doctoral degree in reproductive medicine from Nanjing Medical University in 2014. Recent years, he mainly participated in the study of male reproduction using various proteomic strategies, and was in charge of proteomic data analysis and database construction. Currently, he presided over several scientific research projects at both the national and provincial levels, which were aimed to develop next-generation proteomic softwares and as well as to bring proteomics from bench to bedside for better diagnosis of male infertility and cancers.